Hamps Bio IPO subscription started on Friday, December 13, and will close on December 17 as per the schedule. The price band is set at ₹51 per share with a face value of ₹10.
Hamps Bio IPO Subscription Status
Hamps Bio IPO Subscribed over 10.61x on its First day till 05.00 PM on 13th December.
- Hamps Bio IPO subscription QIB investors portion is 0.00x times, while NII subscribed 2.35x times and RII investors subscribed 18.87x times.
- The company has received bids for 1,22,86,000 shares against 11,58,001 shares on offer on the First day.
- Hamps Bio IPO Subscribed over 10.61x on day 1.
About Hamps Bio IPO
Established in 2007, Hamps Bio is one of the leading companies involved in the marketing and distribution of a wide range of Pharmaceutical products, including tablets, syrups, capsules, injectables, oil, gel, and powder. Other than Pharma products, they also offer freeze-dried and frozen products such as fruits, vegetables, herbs, and flowers. They are widely famous in pharmaceutical products under their own brand name Hamps, while identified for good quality freeze-dried and frozen products by their own brand FzyEzy. Amazon.com, Amazon.ca, Amazon.eu, Flipkart, Jio Mart, etc are some of the E-commerce platforms where they sell their products. Moreover, Hamps Bio Limited has made ₹647.53 lakh so far this year from the sale of pharmaceutical products in 8 states and Union Territories, generating ₹366.43 lakh in revenue for the Fiscal 2024, and freeze-dried and frozen products in 4 countries and 22 states and Union Territories, generating ₹281.10 lakh revenue.
Hamps Bio IPO Company Financial Report
The company reported revenue of ₹6.50 crores in 2024 against ₹5.58 crore in 2023. The company reported a Profit of ₹0.50 crores in 2024 against Profit of ₹0.36 crores in 2023.
Hamps Bio IPO GMP:
Hamps Bio IPO GMP was ₹21 on Friday, December 13th. That indicates the IPO is trading at ₹72 with ₹21 premium in the grey market against the issue price of ₹51.
